CoChat

Metabolomic and glycomic findings in posttraumatic stress disorder

Open access
Konjevod, Marcela, Tudor, Lucija, Svob Strac, Dubravka, Nedic Erjavec, Gordana, Barbas, Coral, Zarkovic, Neven, Nikolac Perkovic, Matea, Uzun, Suzana, Kozumplik, Oliver, Lauc, Gordan, Pivac, Nela · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cited by 47

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Abstract Posttraumatic stress disorder (PTSD) is a stressor‐related disorder that develops in a subset of individuals exposed to a traumatic experience. Factors associated with vulnerability to PTSD are still not fully understood. PTSD is frequently comorbid with various psychiatric and somatic disorders, moderate response to treatment and remission rates. The term “theranostics” combines diagnosis, prognosis, and therapy and offers targeted therapy based on specific analyses. Theranostics, combined with novel techniques and approaches called “omics”, which integrate genomics, transcriptomic, proteomics and metabolomics, might improve knowledge about biological underpinning of PTSD, and offer novel therapeutic strategies. The focus of this review is on metabolomic and glycomic data in PTSD. Metabolomics evaluates changes in the metabolome of an organism by exploring the set of small molecules (metabolites), while glycomics studies the glycome, a complete repertoire of glycan structures with their functional roles in biological systems. Both metabolome and glycome reflect the physiological and pathological conditions in individuals. Only a few studies evaluated metabolic and glycomic changes in patients with PTSD. The metabolomics studies in PTSD patients uncovered different metabolites that might be associated with psychopathological alterations in PTSD. The glycomics study in PTSD patients determined nine N‐glycan structures and found accelerated and premature aging in traumatized subjects and subjects with PTSD based on a GlycoAge index. Therefore, further larger studies and replications are needed. Better understanding of the biological basis of PTSD, including metabolomic and glycomic data, and their integration with other “omics” approaches, might identify new molecular targets and might provide improved therapeutic approaches. HighlightsFactors associated with vulnerability to develop PTSD are still not fully understood.Combination of “omics” approaches might improve knowledge about PTSD.Metabolomics and glycomics data in patients with PTSD are scarce.Metabolomics and glycomics might identify novel diagnostics, prognostics, and possibly theranostics biomarkers in PTSD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pnpbp.2018.07.014

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 47

Metadata

Authors
Konjevod, M., Tudor, L., Svob Strac, D., Nedic Erjavec, G., Barbas, C., Zarkovic, N., Nikolac Perkovic, M., Uzun, S., Kozumplik, O., Lauc, G., & Pivac, N.
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
2019-01
Volume
88
Pages
181-193
ISSN
0278-5846 (ISSN-L)
OpenAlex
W2883823556
Cited by
47
References
32
FWCI
6.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolomic and glycomic findings in posttraumatic stress disorder. https://app.cochat.ai/papers/10.1016/j.pnpbp.2018.07.014
The paper
Konjevod, M., Tudor, L., Svob Strac, D., Nedic Erjavec, G., Barbas, C., Zarkovic, N., Nikolac Perkovic, M., Uzun, S., Kozumplik, O., Lauc, G., & Pivac, N. (2019). Metabolomic and glycomic findings in posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2018.07.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.